Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) EBT Margin (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBT Margin data on record, last reported at 13.59% in Q3 2025.

  • For Q3 2025, EBT Margin rose 117.0% year-over-year to 13.59%; the TTM value through Sep 2025 reached 0.93%, down 965.0%, while the annual FY2024 figure was 0.54%, 862.0% down from the prior year.
  • EBT Margin reached 13.59% in Q3 2025 per CLB's latest filing, up from 9.67% in the prior quarter.
  • Across five years, EBT Margin topped out at 13.59% in Q3 2025 and bottomed at 28.98% in Q4 2024.
  • Average EBT Margin over 4 years is 5.64%, with a median of 9.19% recorded in 2023.
  • The widest YoY moves for EBT Margin: up 323bps in 2024, down -3753bps in 2024.
  • A 4-year view of EBT Margin shows it stood at 9.83% in 2022, then decreased by -13bps to 8.55% in 2023, then tumbled by -439bps to 28.98% in 2024, then soared by 147bps to 13.59% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 13.59% in Q3 2025, 9.67% in Q2 2025, and 1.46% in Q1 2025.